Shape Therapeutics
Founded 2018 · 32 employees on LinkedIn · 3 known investors
ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.
Founders & leadership
Shape Therapeutics was founded in 2018 by Josef von Rickenbach, PhD.
JV
Josef von Rickenbach, PhDinCo-Founder
Investors · 3
Competitors · 2
by search overlapAro Biotherapeutics25 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Stoke Therapeutics24 shared keywords
Companies competing with Shape Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Shape Therapeutics do?
- ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.
- Who founded Shape Therapeutics?
- Shape Therapeutics was founded by Josef von Rickenbach, PhD in 2018.
- Who are Shape Therapeutics's investors?
- Shape Therapeutics's investors include New Enterprise Associates (NEA), Decheng Capital, Mission Biocapital.